Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9672774rdf:typepubmed:Citationlld:pubmed
pubmed-article:9672774lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0002962lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0205042lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0206064lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0524620lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0920563lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:9672774lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:9672774pubmed:issue6lld:pubmed
pubmed-article:9672774pubmed:dateCreated1998-9-9lld:pubmed
pubmed-article:9672774pubmed:abstractTextBetablockers are very effective in patients with angina and angiographically smooth coronary arteries (syndrome X), but may exacerbate the state of insulin resistance that is known to be present in such patients. The aim of the study was to evaluate the effects of short-term treatment with atenolol on carbohydrate metabolism in syndrome X patients, as compared to normal subjects.lld:pubmed
pubmed-article:9672774pubmed:languageenglld:pubmed
pubmed-article:9672774pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9672774pubmed:citationSubsetIMlld:pubmed
pubmed-article:9672774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9672774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9672774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9672774pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9672774pubmed:statusMEDLINElld:pubmed
pubmed-article:9672774pubmed:monthJunlld:pubmed
pubmed-article:9672774pubmed:issn0046-5968lld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:BoniniPPlld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:ChierchiaS...lld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:PagnottaPPlld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:FragassoGGlld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:LocatelliMMlld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:CaumoAAlld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:PiattiPPlld:pubmed
pubmed-article:9672774pubmed:authorpubmed-author:CattaneoNNlld:pubmed
pubmed-article:9672774pubmed:issnTypePrintlld:pubmed
pubmed-article:9672774pubmed:volume28lld:pubmed
pubmed-article:9672774pubmed:ownerNLMlld:pubmed
pubmed-article:9672774pubmed:authorsCompleteYlld:pubmed
pubmed-article:9672774pubmed:pagination623-9lld:pubmed
pubmed-article:9672774pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:meshHeadingpubmed-meshheading:9672774-...lld:pubmed
pubmed-article:9672774pubmed:year1998lld:pubmed
pubmed-article:9672774pubmed:articleTitleDifferential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X).lld:pubmed
pubmed-article:9672774pubmed:affiliationDivision of Cardiology, University of Milan.lld:pubmed
pubmed-article:9672774pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9672774pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9672774pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9672774pubmed:publicationTypeRandomized Controlled Triallld:pubmed